Executive Vice President, Head of Commercial Access & Operations
Meitheal Pharmaceuticals Inc
Summary
Meitheal Pharmaceuticals is seeking an experienced, commercially focused Executive Vice President, Head of Commercial Access & Operations to lead U.S. market access strategy and commercial operating execution in support of its growing biosimilar portfolio and, as assigned, other Company businesses. This executive will be accountable for payer and channel access, pricing and contracting strategy and execution, commercial launch operational readiness jointly with the EVP, distribution and specialty channel execution, commercial analytics, and operational performance.
Job description
Summary
Meitheal Pharmaceuticals is seeking an experienced, commercially focused Executive Vice President, Head of Commercial Access & Operations to lead U.S. market access strategy and commercial operating execution in support of its growing biosimilar portfolio and, as assigned, other Company businesses. This executive will be accountable for payer and channel access, pricing and contracting strategy and execution, commercial launch operational readiness jointly with the EVP, distribution and specialty channel execution, commercial analytics, and operational performance.
The role requires senior-level relationships with payers, PBMs, GPOs, specialty pharmacies, and distributors, combined with the ability to build disciplined, scalable commercial processes. The position leads the commercial access and operations functions assigned to it and partners with the SVP of Specialty and VP of Biosimilars & Women's Health on portfolio priorities and commercialization.
Market Access, Pricing & Contracting
- Develop and execute U.S. market access strategies across pharmacy and medical benefits, retail, specialty, and institutional channels, aligned with cross-functional product and portfolio strategies.
- Lead payer, PBM, health plan, GPO, and strategic account negotiations within approved contracting authority to secure favorable formulary positioning, reimbursement, utilization, and profitable access.
- Lead the development and execution of pricing, rebate, contracting, preferred placement, step-therapy, and other compliant access strategies.
- Monitor payer policy, reimbursement trends, competitive launches, and biosimilar adoption to refine commercial plans.
Commercial Operations & Channel Execution
- Jointly lead commercial launch operational readiness including market access, customer onboarding, distribution setup, contract implementation, and operational milestones.
- Oversee designated commercial channel relationships and operating performance with wholesalers, specialty distributors, specialty pharmacies, and other channel partners.
- Establish effective contract implementation, administration, customer reporting, and performance monitoring processes.
- Develop scalable commercial processes, systems requirements, dashboards, and governance for forecasting, demand planning inputs, customer performance, and issue resolution.
- Partner with Supply Chain to align commercial demand, inventory availability, service levels, and customer commitments.
- Ensure market access, contracting, distribution, and channel practices are developed and implemented in coordination with Legal, Compliance, Regulatory, and Finance.
Financial Performance & Business Insights
- Establish and monitor commercial access and operations KPIs, including preferred access, contract performance, channel utilization, operational launch milestones, and impact on net revenue and profitability.
- Partner with Finance and designated business-unit leaders on product-level P&L reviews, revenue forecasts, gross-to-net assumptions, rebate accrual inputs, contribution margin, and budget discipline.
- Provide cross-functional recommendations on portfolio and product profitability decisions, including pricing trade-offs, channel mix, contract economics, launch investments, and resource allocation.
Executive Leadership & Cross-Functional Coordination
- Build and lead the commercial access and operations functions assigned to this role, with clear decision rights, functional accountability, and collaborative processes.
- Coordinate with Specialty and other business-unit leaders, the EVP, Finance, Legal, Compliance, Regulatory, Medical Affairs, Quality, and Supply Chain to ensure compliant and effective execution.
- Participate in cross-functional business reviews with Finance, Supply Chain, and portfolio leaders to assess performance against product P&L plans.
- Escalate unresolved disagreements over product priorities, customer ownership, pricing economics, or operational execution through established governance processes.
Supervisory Responsibilities
Directly oversee team responsible for Commercial Access and Operations. Provides leadership, coaching, performance management, and strategic direction for growth of biosimilar portfolio.
Core Competencies
- Entrepreneurial mindset with the ability to thrive in a fast-paced, high-growth environment.
- Strategic thinker with outstanding analytical and problem-solving abilities.
- Exceptional communication skills, with the ability to engage internal and external stakeholders, and commercial teams.
- Strong operational execution, balancing high-level strategic vision with hands-on leadership.
- Comprehensive knowledge of regulatory requirements, compliance, and industry standards.
Qualifications
- Required: Direct, substantive Medical Affairs leadership experience with biosimilars, including at least one U.S. biosimilar launch or significant prelaunch commercialization program.
- Required: Working knowledge of FDA biosimilar regulatory pathways, interchangeability, extrapolation, immunogenicity, and scientific communication to healthcare professionals.
- Strongly preferred: Experience supporting biosimilar formulary adoption, payer evidence needs, provider switching education, and collaboration with Market Access.
- Required: MD, PhD, or PharmD required.
- Minimum 15+ years of experience in Pharma/Biotech, 10+ years Medical Affairs department, including leadership roles in biotech/pharmaceutical companies.
- Proficiency with Microsoft Office Suite, including PowerPoint, Word, Excel, and Outlook.
- Ability to travel up to 40%, including overnights. Field-base Role/Remote.
Requirements
- Direct, substantive Medical Affairs leadership experience with biosimilars, including at least one U.S. biosimilar launch or significant prelaunch commercialization program
- Working knowledge of FDA biosimilar regulatory pathways, interchangeability, extrapolation, immunogenicity, and scientific communication to healthcare professionals
- Experience supporting biosimilar formulary adoption, payer evidence needs, provider switching education, and collaboration with Market Access
- MD, PhD, or PharmD required
- Minimum 15+ years of experience in Pharma/Biotech
- 10+ years Medical Affairs department experience
- Leadership roles in biotech/pharmaceutical companies
- Proficiency with Microsoft Office Suite (PowerPoint, Word, Excel, Outlook)
- Ability to travel up to 40%, including overnights
Benefits
- Medical, Dental & Vision
- Flexible Spending Accounts
- Long & Short-Term Disability
- Life Insurance
- 401(k) Matching
- Competitive PTO
- Company-Paid Holidays
- Paid Parental Leave
- Employee Assistance Program
- Onsite Gym
Company overview
Meitheal Pharmaceuticals Inc is a privately owned pharmaceutical company founded in 2017 and headquartered in Chicago, Illinois. The company specializes in generic injectable products and has established itself as a significant player in the pharmaceutical manufacturing sector. With a focus on providing reliable, high-quality, and affordable injectable medications to US healthcare providers, Meitheal operates through strategic global partnerships. The company has demonstrated aggressive growth, expanding its portfolio to include critical care, oncology, anesthesia, and anti-infective products. Meitheal's business model emphasizes simplifying access to life-changing medicine through robust manufacturing capabilities, consistent supply chains, and rapid response to market needs. The company has evolved from a generic injectable focus to include biologics and specialty pharmaceuticals, with a vision of making healthcare solutions more accessible and affordable for patients across various therapeutic areas.